Full-Time

Senior Director

Delivery

Confirmed live in the last 24 hours

Orbital Therapeutics

Orbital Therapeutics

51-200 employees

Develops RNA-based medicines and vaccines

Data & Analytics

Senior

Cambridge, MA, USA

Requirements
  • Ph.D. in Biochemistry, Chemical Engineering, Biology, or related scientific discipline
  • 10+ years of industry experience
  • Familiarity with delivery of nucleic acids
  • Experience in moving technology from preclinical to clinical stages
  • Outstanding teamwork, communication, and interpersonal skills
  • Team leadership experience with a demonstrated track record of personnel development
  • Ability to adapt to increasing scope and complexity of work brought on by growth/change and helps others manage through change
Responsibilities
  • Provide leadership and strategic direction for delivery at Orbital
  • Lead design and synthesis of novel chemical libraries to enhance delivery of nucleic acids in lipid nanoparticles
  • Engage with CDMOs to successfully scale lead compounds
  • Develop with expert scientists virus like particles (VLP) delivery technology
  • Optimize delivery of nucleic acids using either LNP or VLP delivery technologies
  • Work closely with IP to assess patentability, develop patent strategy and lead preparation of patent applications & documents
  • Communicate scientifically rigorous findings and delivery strategy via verbal and written communications, including internal presentations to key stakeholders (e.g. Executive leadership team, Board of Directors) and external presentations
  • Lead, teach and mentor junior staff to promote a culture of growth and learning

Orbital Therapeutics is a leader in RNA-based medicine development, integrating cutting-edge RNA technology, advanced delivery methods, and powerful data analytics. Their collaborative and innovative culture propels the creation of novel vaccines and treatments for immunomodulation, protein replacement, and regenerative medicine, offering a stimulating environment for professionals passionate about impacting human health on a global scale.

Company Stage

Series A

Total Funding

$320M

Headquarters

Cambridge, Massachusetts

Founded

2022

Growth & Insights
Headcount

6 month growth

11%

1 year growth

31%

2 year growth

262%